Abstract
Atopic dermatitis (AD) and contact dermatitis are common eczematous disorders with different inflammatory mechanisms. Understanding the potential links between AD and contact dermatitis, and the parallel aspects of their pathogenesis, diagnosis, and treatment, can be helpful to clinicians caring for patients with these disorders. Immune mediators have been implicated in both AD and allergic contact dermatitis (ACD), i.e., antimicrobial peptides. Optimal treatment of irritant contact dermatitis (ICD) and ACD involves withdrawal or prevention of contact with the offending agent, including the use of protective barriers or complete avoidance of exposure. Patients with AD should undergo patch testing as needed if a diagnosis of concurrent ACD is suspected. AD, ICD, and ACD are all eczematous disorders that represent similar pathological states. Topical calcineurin inhibitors have also proven effective in the treatment of ACD, in both animal and human models.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
